CVS Group plc Directorate Change (4804D)

TIDMCVSG

RNS Number : 4804D

CVS Group plc

22 June 2023

 
 For Immediate Release   22 June 2023

CVS Group plc

("CVS", the "Company" or the "Group")

Appointments of non-executive director and Deputy CEO

CVS, the quoted provider of integrated veterinary services, is pleased to announce the appointment of Joanne Shaw as Non-executive Director with effect from 1 July 2023.

Joanne Mary Shaw (59), has significant healthcare experience from her current roles as Trustee and Audit Committee Chair at Cancer Research UK, Chair at the Royal College of Paediatrics and Child Health, and Deputy Chair at Vitality UK. She has held a number of previous non-executive roles over the past 17 years including as non-executive director and Chair of the Audit and Risk Committee at NHS England and the National Audit Office, Chair of NHS Direct, Non-executive Director at Kensington and Chelsea Primary Care Trust and Chair of the British Equestrian Association. Joanne, who qualified as a chartered accountant, was a former management consultant at Boston Consulting Group and has previous executive roles at the Medicines Partnership, the Audit Commission and Coopers & Lybrand.

In her role of Non-executive Director, Joanne will become a member of the Audit, Remuneration and Nominations committees of the Board.

The Board is also pleased to announce the appointment of Ben Jacklin, Chief Operating Officer, to a newly created role of Deputy CEO, also with effect from 1 July 2023. Ben will retain responsibility for leading the Group's operations in the UK and internationally.

Chairman Richard Connell commented:

"On behalf of the Board I am delighted to welcome Joanne Shaw as a Non-executive Director. Her extensive healthcare experience will support the Board and the wider Group in delivering its purpose to provide the best possible care to animals. The Board looks forward to her input and to working together to deliver further success for the Group.

I am also delighted to congratulate Ben Jacklin on his promotion to Deputy CEO which is a reflection of Ben's significant contribution to the Group over the past few years."

Contacts:

CVS Group plc via Camarco

Richard Fairman, CEO

Ben Jacklin, COO

Robin Alfonso, CFO

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / James Thompson / Milo Bonser

Camarco (Financial PR)

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

Letaba Rimell +44 (0)7789 151 644

Additional Disclosures under the AIM Rules for Companies:

In relation to the appointment of Joanne Shaw, aged 59:

Current directorships/partnerships Past directorships/partnerships

                   Royal College of Paediatrics & Child Health                                    NHS England

Cancer Research UK Nuffield Health

Cancer Research UK Trading Ltd Discovery Holdings Europe Ltd

Imperial Cancer Research Fund

Vitality Corporate Services Ltd

Vitality Health Ltd

Vanguard Metropolitan Ltd

At the date of this announcement Joanne Shaw does not hold any ordinary shares in the Company.

Save for the above, there are no further disclosures to be made in accordance with Rule 17 and 2 paragraph (g) of the AIM Rules for Companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAUAVAROWUNUAR

(END) Dow Jones Newswires

June 22, 2023 02:00 ET (06:00 GMT)

CVS (AQSE:CVSG.GB)
Historical Stock Chart
From Nov 2024 to Dec 2024